載入...
Feasibility of Treating Adults with Ewing or Ewing‐Like Sarcoma with Interval‐Compressed Vincristine, Doxorubicin, and Cyclophosphamide Alternating with Ifosfamide and Etoposide
BACKGROUND: Vincristine, doxorubicin, and cyclophosphamide (VDC) alternating with ifosfamide and etoposide (IE) administered every 2 weeks demonstrated a superior event‐free survival compared with 3‐week dosing in a landmark pediatric trial and is now standard of care for younger patients. Only 12%...
Na minha lista:
| 發表在: | Oncologist |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley & Sons, Inc.
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7011630/ https://ncbi.nlm.nih.gov/pubmed/32043790 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0532 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|